• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry.

作者信息

Hofman Paul, Puchois Pascal, Brest Patrick, Lahlou Hicham, Simeon-Dubach Daniel

机构信息

Université Côte d'Azur, CHU de Nice, Laboratory of Clinical and Experimental Pathology, Biobank (BB-0033-00025), FHU-OncoAge, Nice, France.

Université Côte d'Azur, Institute of Research on Cancer and Ageing of Nice, CNRS, INSERM, Centre Antoine Lacassagne, FHU-OncoAge, Nice, France.

出版信息

Nat Med. 2020 Jun;26(6):809-810. doi: 10.1038/s41591-020-0890-8.

DOI:10.1038/s41591-020-0890-8
PMID:32382152
Abstract
摘要

相似文献

1
Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry.新冠疫情对癌症生物样本库的生物样本用于学术研究和生物产业研究可能产生的后果。
Nat Med. 2020 Jun;26(6):809-810. doi: 10.1038/s41591-020-0890-8.
2
Rethinking Clinical Trials Reform During the COVID-19 Pandemic.新冠疫情期间对临床试验改革的反思
JAMA Oncol. 2020 Sep 1;6(9):1327-1329. doi: 10.1001/jamaoncol.2020.3142.
3
Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.COVID-19大流行期间的肿瘤护理服务：研究创新与结果的契机。
JCO Oncol Pract. 2020 Aug;16(8):431-434. doi: 10.1200/OP.20.00326. Epub 2020 May 28.
4
Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities.COVID-19导致的癌症治疗结果差异——两个城市的故事
JAMA Oncol. 2020 Oct 1;6(10):1531-1532. doi: 10.1001/jamaoncol.2020.3327.
5
Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China.在中国新冠疫情传播期间照顾癌症患者的积极有效措施
JAMA Oncol. 2020 May 1;6(5):631-632. doi: 10.1001/jamaoncol.2020.1198.
6
Palliative Care for Patients With Cancer in the COVID-19 Era.新冠疫情时代癌症患者的姑息治疗
JAMA Oncol. 2020 Oct 1;6(10):1527-1528. doi: 10.1001/jamaoncol.2020.1938.
7
Prevalence of Surface Contamination With SARS-CoV-2 in a Radiation Oncology Clinic.放射肿瘤学诊所中 SARS-CoV-2 表面污染的流行情况。
JAMA Oncol. 2020 Oct 1;6(10):1632-1634. doi: 10.1001/jamaoncol.2020.3552.
8
NCI's Work to Advance Cancer Research while Responding to the COVID-19 Pandemic.NCI 努力推进癌症研究，同时应对 COVID-19 大流行。
Cancer Cell. 2020 Jun 8;37(6):746-748. doi: 10.1016/j.ccell.2020.05.007. Epub 2020 May 16.
9
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.SARS-CoV-2 在武汉一家三级医院癌症患者中的传播。
JAMA Oncol. 2020 Jul 1;6(7):1108-1110. doi: 10.1001/jamaoncol.2020.0980.
10
Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China.中国武汉 COVID-19 疫情期间接受放射治疗的癌症患者的结局。
JAMA Oncol. 2020 Sep 1;6(9):1457-1459. doi: 10.1001/jamaoncol.2020.2783.

引用本文的文献

1
Mobile Efficient Diagnostics of Infectious Diseases via On-Chip RT-qPCR: MEDIC-PCR.基于芯片的实时 RT-qPCR 移动高效传染病诊断：MEDIC-PCR。
Adv Sci (Weinh). 2023 Oct;10(28):e2302072. doi: 10.1002/advs.202302072. Epub 2023 Aug 16.
2
The Availability of Human Biospecimens to Support Biomarker Research.用于支持生物标志物研究的人类生物样本的可获得性。
Biomark Insights. 2022 Apr 19;17:11772719221091750. doi: 10.1177/11772719221091750. eCollection 2022.
3
Biobanking and risk assessment: a comprehensive typology of risks for an adaptive risk governance.

本文引用的文献

1
Transoesophageal endoscopic removal of a benign mediastinal tumour: a new field for endotherapy?经食管内镜切除良性纵隔肿瘤：内镜治疗的新领域？
Gut. 2020 Oct;69(10):1727-1729. doi: 10.1136/gutjnl-2020-321128. Epub 2020 Jun 12.
2
Artificial intelligence-enabled rapid diagnosis of COVID-19 patients.基于人工智能的新冠肺炎患者快速诊断
medRxiv. 2020 Apr 17:2020.04.12.20062661. doi: 10.1101/2020.04.12.20062661.
生物库和风险评估：适应风险治理的风险综合分类。
Life Sci Soc Policy. 2021 Dec 13;17(1):10. doi: 10.1186/s40504-021-00117-7.
4
Basic principles of biobanking: from biological samples to precision medicine for patients.生物样本库的基本原则：从生物样本到患者的精准医疗。
Virchows Arch. 2021 Aug;479(2):233-246. doi: 10.1007/s00428-021-03151-0. Epub 2021 Jul 13.
5
The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials.2019年冠状病毒病对国家临床试验网络乳腺癌试验的影响
Curr Breast Cancer Rep. 2021;13(3):103-109. doi: 10.1007/s12609-021-00417-z. Epub 2021 May 12.
6
Postmortem Findings Associated With SARS-CoV-2: Systematic Review and Meta-analysis.与 SARS-CoV-2 相关的尸检结果：系统评价和荟萃分析。
Am J Surg Pathol. 2021 May 1;45(5):587-603. doi: 10.1097/PAS.0000000000001650.
7
[Management of samples in pathology laboratories and biobanks during the Covid-19 pandemic].[新冠疫情期间病理实验室和生物样本库中的样本管理]
Rev Francoph Lab. 2021 Jan;2021(528):36-42. doi: 10.1016/S1773-035X(20)30392-0. Epub 2021 Jan 7.
8
An Update on Molecular Diagnostics for COVID-19.关于 COVID-19 的分子诊断学的最新进展。
Front Cell Infect Microbiol. 2020 Nov 10;10:560616. doi: 10.3389/fcimb.2020.560616. eCollection 2020.
9
Considerations for diagnostic COVID-19 tests.考虑用于诊断 COVID-19 的检测。
Nat Rev Microbiol. 2021 Mar;19(3):171-183. doi: 10.1038/s41579-020-00461-z. Epub 2020 Oct 14.
10
Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.新冠疫情时代及之后研究生物样本库面临的机遇与风险
Biopreserv Biobank. 2020 Dec;18(6):503-510. doi: 10.1089/bio.2020.0079. Epub 2020 Oct 8.